PhosphOmega-3® - NEW!

Dietary Supplement

PhosphOmega-3® is NOT just another fish oil, but the first major advancement in Omega-3 Science in 30 years.  Just two tablets equal the clinical effects on cholesterol metabolism equal to 4-6 grams of fish oil. Naturally bound to phospholipids, PhosphOmega-3® has 50 times greater absorption than fish oil†. Scientific research has shown that Omega-3 fatty acids bound to phospholipids have greatly enhanced bioavailability and stability than fatty acids on triglyceride carriers such as fish oil.

PhosphOmega-3® is 100% sustainable and derived from 100% pure North Atlantic Salmon. Its patented extraction process uses no heat, chemicals, or solvents. Each batch of PhosphOmega-3® is tested and passes both US and European standards for purity. EuroMedica® uses the highest sensitivity tests available to assure your patients health and safety. In fact, it would take over 150,000 PhosphOmega-3® tablets to be taken at one time to exceed the safety level established by the State of California (90ng)

In a recent clinical trial, subjects using PhosphOmega-3® experienced significant support in healthy total cholesterol, triglycerides, and HDL levels. In addition, they reported significant improvement in several factors including an improvement in concentration, mental vigor, quality of sleep, visual fatigue, long term and short term memory, and physical recovery.

PhosphOmega-3® is easy and effective for patients to use. Just 2 tablets daily deliver results you and your patients can rely on.  Unique in every way PhosphOmega-3® is clearly a superior choice.

PhosphOmega-3® BROCHURE

^{†Comparative in-vitro study of the intestinal permeability and bioaccumulation of omega-3 fatty acids in PhosphOmega-3® using the CACO-2 epithelium intestinal model. Rennes, France.}

^{Heavy metal analysis has been conducted on every batch using ICP-MS and found to be pure and safe.}

^References:

^{1. Linder M, Fanni J, Parmentier M, Regnault P. Procede d’obtention d’une huile et d’un hydrolysat de proteins a partir d’une source marine de tissus proteiques et huile et hydrolysat de proteins obtenus par mise en oeuvre de ce procede. French patent number 2,835,703. August 15, 2003.}

^{2. Bracco U. Effect of triglyceride structure on fat absorption. Am J Clin Nutr. 1994 Dec;60(6 Suppl):1002S-1009S.}

^{3. Ramírez M, Amate L, Gil A. Absorption and distribution of dietary fatty acids from different sources. Early Hum Dev. 2001 Nov;65 Suppl:S95-S101.}

^{4. Cansell M, Nacka F, Combe N. Marine lipid-based liposomes increase in vivo FA bioavailability. Lipids. 2003 May;38(5):551-9.}

^{5. Thies F, Pillon C, Moliere P, Lagarde M, Lecerf J. Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am J Physiol. 1994 Nov;267(5 Pt 2):R1273-9.}

SUPPLEMENT FACTS

Serving Size: 1 Tablet

Other Ingredients: maltodextrin, tricalcium phosphate, cellulose, silica, titanium dioxide, stearic acide, iron oxide

Contains no: sugar, salt, soy, yeast, wheat, gluten, corn, artificial coloring, artificial flavoring or preservatives. It contains only natural ingredients. Color variations are normal. Could be suitable for some vegetarians. No animal by-products.

¹Based on the Caco-2 Absorption Model

Product of France